BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 10389597)

  • 1. Neuropsychological assessment of older adults with Down's syndrome: an epidemiological study using the Cambridge Cognitive Examination (CAMCOG).
    Hon J; Huppert FA; Holland AJ; Watson P
    Br J Clin Psychol; 1999 Jun; 38(2):155-65. PubMed ID: 10389597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The modified CAMDEX informant interview is a valid and reliable tool for use in the diagnosis of dementia in adults with Down's syndrome.
    Ball SL; Holland AJ; Huppert FA; Treppner P; Watson P; Hon J
    J Intellect Disabil Res; 2004 Sep; 48(Pt 6):611-20. PubMed ID: 15312062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A German version of the Cambridge examination for mental disorders of older people with Down's syndrome and others with intellectual disabilities : A diagnostic procedure for detecting dementia in people with Down's syndrome].
    Nübling G; Loosli SV; Wlasich E; Prix C; Schönecker S; Freudelsperger L; Smrzka N; Strydom AM; Zaman SH; Benejam B; Missios J; Meister R; Danek A; Levin J
    Z Gerontol Geriatr; 2020 Oct; 53(6):546-551. PubMed ID: 31399752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring impairments in memory and executive function in older people using the Revised Cambridge Cognitive Examination.
    Kessels RP; Mimpen G; Melis R; Rikkert MG
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):793-801. PubMed ID: 19700951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adaptation and validation of CAMDEX-DS (Cambridge Examination for Mental Disorders of Older People with Down's Syndrome and others with intellectual disabilities) in Spanish population with intellectual disabilities].
    Esteba-Castillo S; Dalmau-Bueno A; Ribas-Vidal N; Vilà-Alsina M; Novell-Alsina R; García-Alba J
    Rev Neurol; 2013 Oct; 57(8):337-46. PubMed ID: 24081888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CAMCOG--a concise neuropsychological test to assist dementia diagnosis: socio-demographic determinants in an elderly population sample.
    Huppert FA; Brayne C; Gill C; Paykel ES; Beardsall L
    Br J Clin Psychol; 1995 Nov; 34(4):529-41. PubMed ID: 8563660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress.
    Fonseca LM; Mattar GP; Haddad GG; Burduli E; McPherson SM; Guilhoto LMFF; Yassuda MS; Busatto GF; Bottino CMC; Hoexter MQ; Chaytor NS
    J Alzheimers Dis; 2021; 81(1):137-154. PubMed ID: 33749644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.
    Margallo-Lana ML; Moore PB; Kay DW; Perry RH; Reid BE; Berney TP; Tyrer SP
    J Intellect Disabil Res; 2007 Jun; 51(Pt. 6):463-77. PubMed ID: 17493029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between the CAMCOG, the MMSE, and three clock drawing tests in a specialized outpatient psychogeriatric service.
    Heinik J; Solomesh I; Berkman P
    Arch Gerontol Geriatr; 2004; 38(1):77-84. PubMed ID: 14599707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome.
    Holland AJ; Hon J; Huppert FA; Stevens F; Watson P
    Br J Psychiatry; 1998 Jun; 172():493-8. PubMed ID: 9828989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Personality and behaviour changes mark the early stages of Alzheimer's disease in adults with Down's syndrome: findings from a prospective population-based study.
    Ball SL; Holland AJ; Hon J; Huppert FA; Treppner P; Watson PC
    Int J Geriatr Psychiatry; 2006 Jul; 21(7):661-73. PubMed ID: 16802281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Executive dysfunction and its association with personality and behaviour changes in the development of Alzheimer's disease in adults with Down syndrome and mild to moderate learning disabilities.
    Ball SL; Holland AJ; Treppner P; Watson PC; Huppert FA
    Br J Clin Psychol; 2008 Mar; 47(Pt 1):1-29. PubMed ID: 17681112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of dementia and cognitive impairment in a community population of elderly people with Parkinson's disease by use of the CAMCOG neuropsychological test.
    Hobson P; Meara J
    Age Ageing; 1999 Jan; 28(1):39-43. PubMed ID: 10203203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset Alzheimer's disease is associated with a distinct neuropsychological profile.
    Smits LL; Pijnenburg YA; Koedam EL; van der Vlies AE; Reuling IE; Koene T; Teunissen CE; Scheltens P; van der Flier WM
    J Alzheimers Dis; 2012; 30(1):101-8. PubMed ID: 22366769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive assessment of a representative community population with Parkinson's disease (PD) using the Cambridge Cognitive Assessment-Revised (CAMCOG-R).
    Athey RJ; Porter RW; Walker RW
    Age Ageing; 2005 May; 34(3):268-73. PubMed ID: 15863411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A four year prospective study of age-related cognitive change in adults with Down's syndrome.
    Oliver C; Crayton L; Holland A; Hall S; Bradbury J
    Psychol Med; 1998 Nov; 28(6):1365-77. PubMed ID: 9854278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-national comparisons of the Cambridge Cognitive Examination-revised: the CAMCOG-R: results from the European Harmonization Project for Instruments in Dementia.
    Verhey FR; Huppert FA; Korten EC; Houx P; de Vugt M; van Lang N; DeDeyn PP; Saerens J; Neri M; de Vreese L; Peña-Casanova J; Böhm P; Stoppe G; Fleischmann U; Wallin A; Hellström P; Middelkoop H; Bollen W; Klinkenberg EL; Derix MM; Jolles J
    Age Ageing; 2003 Sep; 32(5):534-40. PubMed ID: 12958004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of praxis test from Cambridge Cognitive Examination (CAMCOG) for Alzheimer's disease: a cross-sectional study.
    Cecato JF; Melo BAR; Moraes GC; Martinelli JE; Montiel JM
    Sao Paulo Med J; 2018; 136(5):390-397. PubMed ID: 30570090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theoretical exploration of the neural bases of behavioural disinhibition, apathy and executive dysfunction in preclinical Alzheimer's disease in people with Down's syndrome: potential involvement of multiple frontal-subcortical neuronal circuits.
    Ball SL; Holland AJ; Watson PC; Huppert FA
    J Intellect Disabil Res; 2010 Apr; 54(4):320-36. PubMed ID: 20202073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The accuracy of the Clock Drawing Test compared to that of standard screening tests for Alzheimer's disease: results from a study of Brazilian elderly with heterogeneous educational backgrounds.
    Aprahamian I; Martinelli JE; Neri AL; Yassuda MS
    Int Psychogeriatr; 2010 Feb; 22(1):64-71. PubMed ID: 19814841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.